Steven Valiquette
Stock Analyst at Mizuho
(2.90)
# 1,448
Out of 4,814 analysts
109
Total ratings
56.36%
Success rate
3.13%
Average return
Main Sectors:
Stocks Rated by Steven Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MCK McKesson | Maintains: Neutral | $630 → $690 | $697.08 | -1.02% | 3 | Apr 3, 2025 | |
| CAH Cardinal Health | Maintains: Outperform | $142 → $150 | $134.68 | +11.38% | 6 | Mar 31, 2025 | |
| ALGN Align Technology | Maintains: Outperform | $295 → $250 | $171.41 | +45.85% | 10 | Mar 25, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $21 → $18 | $12.84 | +40.19% | 7 | Mar 13, 2025 | |
| SOLV Solventum | Maintains: Neutral | $70 → $82 | $65.70 | +24.81% | 2 | Mar 3, 2025 | |
| DOCS Doximity | Maintains: Neutral | $55 → $65 | $53.20 | +22.18% | 2 | Feb 10, 2025 | |
| VEEV Veeva Systems | Maintains: Outperform | $275 → $280 | $220.66 | +26.89% | 2 | Dec 9, 2024 | |
| LFMD LifeMD | Initiates: Neutral | $7 | $5.10 | +37.39% | 1 | Dec 4, 2024 | |
| HQY HealthEquity | Initiates: Outperform | $126 | $84.52 | +49.08% | 1 | Dec 4, 2024 | |
| HSIC Henry Schein | Initiates: Neutral | $75 | $64.28 | +16.68% | 5 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $2.67 | +87.27% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $20 | $15.19 | +31.67% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $14 | $6.65 | +110.53% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $142 | $174.51 | -18.63% | 10 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $55 | $67.75 | -18.82% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $82 → $92 | $147.27 | -37.53% | 10 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $565 | $454.11 | +24.42% | 5 | Apr 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $100 | $67.28 | +48.63% | 1 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $14 | $5.46 | +156.41% | 1 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $380 → $400 | $322.37 | +24.08% | 4 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $107 | $60.68 | +76.33% | 1 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $22 → $17 | $28.75 | -40.86% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $5 → $12 | $6.21 | +93.24% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $96 | $103.53 | -7.27% | 3 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $105 → $120 | $163.77 | -26.73% | 6 | Apr 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $127 | $334.38 | -62.02% | 1 | Apr 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $327 → $358 | $264.38 | +35.41% | 3 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $20 → $16 | $31.33 | -48.93% | 3 | Aug 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $78 → $60 | $10.80 | +455.56% | 3 | Apr 3, 2019 |
McKesson
Apr 3, 2025
Maintains: Neutral
Price Target: $630 → $690
Current: $697.08
Upside: -1.02%
Cardinal Health
Mar 31, 2025
Maintains: Outperform
Price Target: $142 → $150
Current: $134.68
Upside: +11.38%
Align Technology
Mar 25, 2025
Maintains: Outperform
Price Target: $295 → $250
Current: $171.41
Upside: +45.85%
DENTSPLY SIRONA
Mar 13, 2025
Maintains: Neutral
Price Target: $21 → $18
Current: $12.84
Upside: +40.19%
Solventum
Mar 3, 2025
Maintains: Neutral
Price Target: $70 → $82
Current: $65.70
Upside: +24.81%
Doximity
Feb 10, 2025
Maintains: Neutral
Price Target: $55 → $65
Current: $53.20
Upside: +22.18%
Veeva Systems
Dec 9, 2024
Maintains: Outperform
Price Target: $275 → $280
Current: $220.66
Upside: +26.89%
LifeMD
Dec 4, 2024
Initiates: Neutral
Price Target: $7
Current: $5.10
Upside: +37.39%
HealthEquity
Dec 4, 2024
Initiates: Outperform
Price Target: $126
Current: $84.52
Upside: +49.08%
Henry Schein
Dec 4, 2024
Initiates: Neutral
Price Target: $75
Current: $64.28
Upside: +16.68%
Dec 4, 2024
Initiates: Outperform
Price Target: $5
Current: $2.67
Upside: +87.27%
Dec 4, 2024
Initiates: Underperform
Price Target: $20
Current: $15.19
Upside: +31.67%
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $18 → $14
Current: $6.65
Upside: +110.53%
Sep 21, 2023
Maintains: Equal-Weight
Price Target: $142
Current: $174.51
Upside: -18.63%
Aug 4, 2023
Maintains: Overweight
Price Target: $55
Current: $67.75
Upside: -18.82%
Aug 2, 2023
Maintains: Overweight
Price Target: $82 → $92
Current: $147.27
Upside: -37.53%
Apr 14, 2023
Maintains: Overweight
Price Target: $565
Current: $454.11
Upside: +24.42%
Mar 30, 2023
Maintains: Overweight
Price Target: $110 → $100
Current: $67.28
Upside: +48.63%
Feb 27, 2023
Maintains: Overweight
Price Target: $17 → $14
Current: $5.46
Upside: +156.41%
Oct 28, 2022
Maintains: Overweight
Price Target: $380 → $400
Current: $322.37
Upside: +24.08%
Jul 28, 2022
Reinstates: Overweight
Price Target: $107
Current: $60.68
Upside: +76.33%
Apr 18, 2022
Downgrades: Equal-Weight
Price Target: $22 → $17
Current: $28.75
Upside: -40.86%
Jun 11, 2021
Upgrades: Overweight
Price Target: $5 → $12
Current: $6.21
Upside: +93.24%
Nov 23, 2020
Upgrades: Overweight
Price Target: $96
Current: $103.53
Upside: -7.27%
Apr 30, 2020
Reiterates: Neutral
Price Target: $105 → $120
Current: $163.77
Upside: -26.73%
Apr 22, 2020
Maintains: Overweight
Price Target: $117 → $127
Current: $334.38
Upside: -62.02%
Dec 6, 2019
Maintains: Overweight
Price Target: $327 → $358
Current: $264.38
Upside: +35.41%
Aug 30, 2019
Maintains: Underweight
Price Target: $20 → $16
Current: $31.33
Upside: -48.93%
Apr 3, 2019
Maintains: Equal-Weight
Price Target: $78 → $60
Current: $10.80
Upside: +455.56%